Literature Collection

Magnifying Glass
Collection Insights

12K+

References

11K+

Articles

1600+

Grey Literature

4800+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
12762 Results
12021
Treatment and Follow-up Care Associated With Patient-Scheduled Primary Care Telemedicine and In-Person Visits in a Large Integrated Health System
Type: Journal Article
Authors: M. Reed, J. Huang, I. Graetz, E. Muelly, A. Millman, C. Lee
Year: 2021
Abstract:

IMPORTANCE: Telemedicine visits can offer patients convenient access to a clinician, but it is unclear whether treatment differs from that with in-person visits or how often patients require in-person follow-up. OBJECTIVE: To examine whether physician prescribing and orders differ between telemedicine and office visits, whether physicians conducting telemedicine visits are more likely to require in-person follow-up, and whether telemedicine visits are associated with more health events. DESIGN, SETTING, AND PARTICIPANTS: This cohort study included all patients who scheduled primary care appointments through the patient portal of a large integrated health care delivery system newly implementing patient-scheduled video telemedicine visits from January 2016 to May 2018. MAIN OUTCOMES AND MEASURES: Adjusted rates of any medication prescribed or laboratory tests or imaging ordered and rates of follow-up health care utilization (in-person visits, emergency department visits, and hospitalizations) within 7 days after the index visit, stratified by index primary care visit type, were generated using multivariable adjustment for patient, access, and clinical characteristics. RESULTS: This study included 1 131 722 patients (611 821 [54%] female; mean [SD] age, 43 [22] years) with 2 178 440 total appointments (307 888 [14%] telemedicine), of which 13.5% were for patients younger than 18 years, 22.2% were for patients 65 years or older, and 54.9% were for female patients. After adjustment, 38.6% (95% CI, 38.0%-39.3%) of video visits, 34.7% (95% CI, 34.5%-34.9%) of telephone visits, and 51.9% (95% CI, 51.8%-52.0%) of office visits had any medication prescribed; laboratory tests or imaging were ordered for 29.2% (95% CI, 28.5%-29.8%) of video visits, 27.3% (95% CI, 27.1%-27.5%) of telephone visits, and 59.3% (95% CI, 59.3%-59.4%) of clinic visits. After adjustment, follow-up visits within 7 days occurred after 25.4% (95% CI, 24.7%-26.0%) of video visits, 26.0% (95% CI, 25.9%-26.2%) of telephone visits, and 24.5% (95% CI, 24.5%-24.6%) of office visits. Adjusted emergency department visits and rates of hospitalizations were not statistically significantly different by primary care index visit type. CONCLUSIONS AND RELEVANCE: In this cohort study of patient self-scheduled primary care telemedicine visits within ongoing patient-physician relationships, prescribing and orders were significantly lower for telemedicine visits than for clinic visits, with slightly higher follow-up office visits for telemedicine but no difference in health events (emergency department visits or hospitalizations). Video or telephone visits may be a convenient and efficient way to access primary care and address patient needs.

Topic(s):
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
,
HIT & Telehealth See topic collection
12022
Treatment barriers and preferences among veterans with chronic musculoskeletal pain and alcohol use in primary care
Type: Journal Article
Authors: K. A. Buckheit, J. Scharer, T. A. Loughran, G. P. Beehler, D. Moskal, J. S. Funderburk
Year: 2025
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
12023
Treatment completion on an inpatient detoxification unit: impact of a change to sublingual buprenorphine-naloxone
Type: Journal Article
Authors: J. M. Soeffing, D. A. Rastegar
Year: 2007
Publication Place: United States
Abstract: PURPOSE: Buprenorphine is commonly used for opioid detoxification. The goal of this study was to determine whether a change from the intramuscular (IM) buprenorphine to the sublingual (SL) formulation of buprenorphine-naloxone was associated with improved treatment completion rates on an inpatient detoxification unit. METHODS: This study was conducted at the Johns Hopkins Bayview Medical Center (JHBMC) Chemical Dependence Unit (CDU), a 26-bed, 3-day inpatient detoxification unit providing detoxification from opioids, alcohol, and sedatives. The opioid detoxification protocol was changed from IM buprenorphine (0.3 mg bid for 3 days) to SL buprenorphine-naloxone (8, 8, and 6 mg on sequential days, plus 2 mg on the morning of discharge). For the 3 months prior to and after the change in protocol, data were collected retrospectively on demographics, type of dependence being treated, and type of discharge. FINDINGS: A total of 1,168 patients were admitted to the JHBMC CDU during the period studied. In the 3 months prior to the change in buprenorphine protocol, 353 of 483 patients admitted for treatment of opioid dependence (73.1%) completed treatment, compared with 407 of 473 patients admitted after the change (86.0%); this difference was highly significant (p < .0001). Among 212 patients who did not receive treatment for opioid dependence over the same period, the rates of treatment completion did not change significantly (89.8% before vs. 83.0% after; p = .208). CONCLUSIONS: A change from IM buprenorphine to SL buprenorphine-naloxone for opioid detoxification was associated with a significant improvement in completion rates at this inpatient treatment program.
Topic(s):
Opioids & Substance Use See topic collection
12024
Treatment compliance among incarcerated and fined amphetamine-type-stimulant (ATS) users in a community supervision programme in Malaysia: A preliminary study
Type: Journal Article
Authors: Darshan Singh, Nadiah Saref, Suresh Narayanan, O. H. Griffin, Balasingam Vicknasingam
Year: 2021
Topic(s):
Education & Workforce See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
12025
Treatment Considerations for Youth and Young Adults with Serious Emotional Disturbances and Serious Mental Illnesses and Co-occurring Substance Use
Type: Government Report
Authors: Substance Abuse and Mental Health Services Administration
Year: 2021
Publication Place: Rockville, MD
Topic(s):
Grey Literature See topic collection
,
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

12026
Treatment costs, cost offset, and cost-effectiveness of collaborative management of depression
Type: Journal Article
Authors: M. Von Korff, W. Katon, T. Bush, E. H. Lin, G. E. Simon, K. Saunders, E. Ludman, E. Walker, J. Unutzer
Year: 1998
Topic(s):
Financing & Sustainability See topic collection
12027
Treatment Differences in Primary and Specialty Settings in Veterans with Major Depression
Type: Journal Article
Authors: V. Puac-Polanco, L. B. Leung, R. M. Bossarte, C. Bryant, J. N. Keusch, H. Liu, H. N. Ziobrowski, W. R. Pigeon, D. W. Oslin, E. P. Post, R. C. Kessler
Year: 2021
Topic(s):
Healthcare Disparities See topic collection
12028
Treatment engagement and response to CBT among Latinos with anxiety disorders in primary care
Type: Journal Article
Authors: Denise A. Chavira, Daniela Golinelli, Cathy D. Sherbourne, Murray B. Stein, Greer Sullivan, Alexander Bystritsky, Raphael D. Rose, Ariel Janna Lang, Laura Campbell-Sills, Stacy Shaw Welch, Kristin Bumgardner, Daniel E. Glenn, Velma Barrios, Peter P. Roy-Byrne, Michelle G. Craske
Year: 2014
Topic(s):
Healthcare Disparities See topic collection
12029
Treatment Episode Data Set (TEDS) 2021: Admissions to and Discharges from Substance Use Treatment Services Reported by Single State Agencies
Type: Web Resource
Authors: Substance Abuse and Mental Health Services Administration
Year: 2023
Publication Place: Rockville, MD
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

12030
Treatment Episode Data Set (TEDS) 2022: Admissions to and Discharges from Substance Use Treatment Services Reported by Single State Agencies
Type: Web Resource
Authors: Substance Abuse and Mental Health Services Administration
Year: 2024
Publication Place: Rockville, MD
Topic(s):
Opioids & Substance Use See topic collection
,
Healthcare Disparities See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

12031
Treatment for opioid use and outcomes in older adults: A systematic literature review
Type: Journal Article
Authors: Anne Marie Carew, Catherine Comiskey
Year: 2018
Topic(s):
Healthcare Disparities See topic collection
,
Opioids & Substance Use See topic collection
12032
Treatment for Opioid Use Disorder in Primary Care: Opportunities and Challenges for Sustainable Training Programs
Type: Journal Article
Authors: Heather Klusaritz, Andrea Bilger, Emily Paterson, Courtney Summers, Frances K. Barg, Peter F. Cronholm, Julie Sochalski
Year: 2020
Publication Place: Baltimore
Topic(s):
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection
12033
Treatment for opioid use disorder in the Florida medicaid population: Using a cascade of care model to evaluate quality
Type: Journal Article
Authors: K. Johnson, H. Hills, J. Ma, C. H. Brown, M. McGovern
Year: 2021
Abstract:

Background: A cascade of care (CoC) model may improve understanding of gaps in addiction treatment availability and quality over current single measure methods. Despite increased funding, opioid overdose rates remain high. Therefore, it is critical to understand where the health-care system is failing to provide appropriate care for people with opioid use disorder (OUD) diagnoses, and to assess disparities in receipt of medication for OUD (MOUD).Objective: Using a CoC framework, assess treatment quality and outcomes for OUD in the Florida Medicaid population in 2017/2018 by demographics and primary vs. secondary diagnosis.Methods: Data from Florida Medicaid claims for 2017 and 2018 were used to calculate the number of enrollees who were diagnosed, began MOUD, were retained on medication for a minimum of 180 days, and who died.Results: Only 28% of those diagnosed with OUD began treatment with an FDA approved MOUD (buprenorphine, methadone, or injectable naltrexone). Once on medication, 38% of newly diagnosed enrollees were retained in treatment for180 days. Those who remained on MOUD for 180 days had a hazard ratio of death of 0.226 (95% CI = 0.174 to 0.294) compared to those that did not initiate MOUD, a reduction in mortality from 10% without MOUD to 2% with MOUD.Conclusions: Initiating medication after OUD diagnosis offers the greatest opportunity for intervention to reduce overdose deaths, though efforts to increase retention are also warranted. Analyzing claims data with CoC identifies system functioning for specific populations, and suggests policies and clinical pathways to target for improvement.

Topic(s):
Financing & Sustainability See topic collection
,
Opioids & Substance Use See topic collection
12034
Treatment Improvement Protocol (TIP) 37: Substance Abuse Treatment for Persons With HIV/AIDS
Type: Government Report
Authors: Center for Substance Abuse Treatment
Year: 2000
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

12035
Treatment Improvement Protocol (TIP) 50: Addressing Suicidal Thoughts and Behaviors in Substance Abuse Treatment
Type: Government Report
Authors: Center for Substance Abuse Treatment
Year: 2009
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

12036
Treatment Improvement Protocol (TIP) 53: Addressing Viral Hepatitis in People With Substance Use Disorders
Type: Government Report
Authors: Substance Abuse and Mental Health Services Administration
Year: 2011
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

12037
Treatment Improvement Protocol (TIP) 60: Using Technology-Based Therapeutic Tools in Behavioral Health Services
Type: Government Report
Authors: Substance Abuse and Mental Health ServicesAdministration
Year: 2015
Topic(s):
Grey Literature See topic collection
,
HIT & Telehealth See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

12038
Treatment Improvement Protocol (TIP) 63: Medications for Opioid Use Disorders
Type: Government Report
Authors: Substance Abuse and Mental Health Services Administration
Year: 2018
Topic(s):
Grey Literature See topic collection
,
Education & Workforce See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

12039
Treatment Improvement Protocol 41: Substance Abuse Treatment: Group Therapy
Type: Government Report
Authors: Center for Substance Abuse Treatment
Year: 2005
Topic(s):
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

12040
Treatment Initiation Following Positive Depression Screens in Primary Care: a Propensity Score-Weighted Analysis of Integrated Mental Health Services
Type: Journal Article
Authors: B. L. Cornwell, B. R. Szymanski, K. M. Bohnert, J. F. McCarthy
Year: 2020
Publication Place: United States
Abstract:

In 2007, the Veterans Health Administration (VHA) began national implementation of Primary Care-Mental Health Integration (PCMHI) services. A major goal was to enhance mental health access and address unmet treatment needs. Integrated care services have been shown to improve depression identification1 and enhance engagement in specialty mental health treatment.2 Szymanski et al. examined a sample of VHA users in fiscal year (FY) 2010 and documented positive associations between receipt of PCMHI services on the day of a positive depression screen and initiation of depression treatment within 12 weeks.3 The authors noted as a study limitation that individuals who had received same-day PCMHI services may have had unmeasured differences in symptom severity or willingness to initiate depression treatment, as compared with other study patients.3 Also, in the years since 2010, VHA implementation of PCMHI services has expanded substantially. The present analysis re-evaluates the influence of same-day PCMHI services on initiation of depression treatment, for a more recent period and adjusting for patient propensity to have received PCMHI and/or Specialty Mental Health (SMH) clinic services on the day of the initial positive depression screen in primary care (PC). METHODS For FY2017 data, we applied methods from the FY2010 study,3 adding use of propensity score weights to adjust for patient likelihood of receiving same-day PCMHI and/or SMH services.4, 5 Generalized boosted models4, 5 were used to create the weights, with location of same-day services as the outcome. Separate propensity score–weighted logistic regressions assessed initiation within 12 weeks of antidepressant pharmacotherapy, psychotherapy, and either treatment.4 Analyses used SAS (version 9.3) and R software (version 3.4.2). The study was conducted as part of ongoing operations in the VHA Office of Mental Health and Suicide Prevention. RESULTS Table 1 presents sample characteristics, by type of services received. Compared with patients receiving same-day PCMHI, the “PC only” patients were older (38.4% vs. 23.1% were 65+ years old); less likely to be Hispanic (7.7% vs. 8.9%); more likely to be male (87.8% vs. 85.7%), married (49.2% vs. 45.8%), with a prior mental health diagnosis (16.7% vs. 13.3%) and prior VHA outpatient use (67.1% vs. 64.6%); and had lower baseline PHQ-2 (Patient Health Questionnaire) scores (4.64 vs. 4.83).

Topic(s):
Healthcare Disparities See topic collection
,
Measures See topic collection